Regional gastrointestinal transit and pH studied in 215 healthy volunteers using the wireless motility capsule: Influence of age, gender, study country and testing protocol

Alimentary Pharmacology and Therapeutics

Volumn 42, Issue 6, 2015, Pages 761-772

  Wang, Y T ^a   Mohammed, S D ^a   Farmer, A D ^a,b   Wang, D ^c   Zarate, N ^d   Hobson, A R ^e   Hellstrom P M ^f   Semler, J R ^g   Kuo, B ^h   Rao, S S ⁱ   Hasler, W L ^j   Camilleri, M ^k   Scott, S M ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^e Functional Gut Clinic   (United Kingdom)

^f UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^g MEDTRONIC INC   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ MEDICAL COLLEGE OF GEORGIA   (United States)

^j UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^k Clinical Enteric Neuroscience Translational and Epidemiological Research Mayo Clinic   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CLINICAL PROTOCOL; CLUSTER ANALYSIS; COLONIC TRANSIT TIME; CONTROLLED STUDY; DIGESTIVE TRACT PARAMETERS; FEMALE; FOOD INTAKE; GASTRIC EMPTYING TIME; GASTROINTESTINAL PH; GASTROINTESTINAL TRANSIT; GASTROINTESTINAL TRANSIT TIME; GEOGRAPHIC ORIGIN; HUMAN; HUMAN EXPERIMENT; INTESTINE TRANSIT TIME; MALE; MOTILITY CAPSULE; NORMAL HUMAN; PH; PH MEASUREMENT; PRIORITY JOURNAL; SEX DIFFERENCE; SMALL BOWEL TRANSIT TIME; STOMACH EMPTYING; SWEDEN; UNITED STATES; VOLUNTEER; WHOLE GUT TRANSIT TIME; WIRELESS MOTILITY CAPSULE; CAPSULE ENDOSCOPY; CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; PHYSIOLOGY; PROCEDURES; TIME FACTOR;

ADULT; AGE FACTORS; CAPSULE ENDOSCOPY; CLINICAL PROTOCOLS; FEMALE; GASTRIC EMPTYING; GASTROINTESTINAL TRANSIT; HEALTHY VOLUNTEERS; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; SEX FACTORS; SWEDEN; TIME FACTORS; UNITED STATES;

EID: 84939565120     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13329     Document Type: Article

References (56)

1. Everhart JE, Ruhl CE,. Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases. Gastroenterology 2009; 136: 376-86.
2. Everhart JE, Ruhl CE,. Burden of digestive diseases in the United States part II: lower gastrointestinal diseases. Gastroenterology 2009; 136: 741-54.
3. Sadik R, Stotzer PO, Simren M, Abrahamsson H,. Gastrointestinal transit abnormalities are frequently detected in patients with unexplained GI symptoms at a tertiary centre. Neurogastroenterol Motil 2008; 20: 197-205.
4. Manabe N, Wong BS, Camilleri M, Burton D, McKinzie S, Zinsmeister AR,. Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort. Neurogastroenterol Motil 2010; 22: 293-e82.
5. Rao SS, Camilleri M, Hasler WL, et al,. Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies. Neurogastroenterol Motil 2011; 23: 8-23.
6. Zarate N, Knowles CH, Yazaki E, Lunnis PJ, Scott SM,. Clinical presentation and patterns of slow transit constipation do not predict coexistent upper gut dysmotility. Dig Dis Sci 2009; 54: 122-31.
7. Bonapace ES, Maurer AH, Davidoff S, Krevsky B, Fisher RS, Parkman HP,. Whole gut transit scintigraphy in the clinical evaluation of patients with upper and lower gastrointestinal symptoms. Am J Gastroenterol 2000; 95: 2838-47.
8. Camilleri M, Bharucha AE, di Lorenzo C, et al,. American Neurogastroenterology and Motility Society consensus statement on intraluminal measurement of gastrointestinal and colonic motility in clinical practice. Neurogastroenterol Motil 2008; 20: 1269-82.
9. Bouras EP, Burton DD, Camilleri M, Stephens DA, Thomforde GM,. Effect of cyclooxygenase-2 inhibitors on gastric emptying and small intestinal transit in humans. Neurogastroenterol Motil 2004; 16: 729-35.
10. Camilleri M, Iturrino J, Bharucha AE, et al,. Performance characteristics of scintigraphic measurement of gastric emptying of solids in healthy participants. Neurogastroenterol Motil 2012; 24: 1076-e562.
11. Dinning PG, Smith TK, Scott SM,. Pathophysiology of colonic causes of chronic constipation. Neurogastroenterol Motil 2009; 21 (Suppl. 2): 20-30.
12. [Measurement of colonic transit time (total and segmental) with radiopaque markers. National reference values obtained in 192 healthy subjects. Spanish Group for the Study of Digestive Motility]. Gastroenterol Hepatol 1998; 21: 71-5.
13. Evans RC, Kamm MA, Hinton JM, Lennard-Jones JE,. The normal range and a simple diagram for recording whole gut transit time. Int J Colorectal Dis 1992; 7: 15-7.
14. Bouchoucha M, Devroede G, Dorval E, Faye A, Arhan P, Arsac M,. Different segmental transit times in patients with irritable bowel syndrome and "normal" colonic transit time: is there a correlation with symptoms? Tech Coloproctol 2006; 10: 287-96.
15. Danquechin Dorval E, Barbieux JP, Picon L, Alison D, Codjovi P, Rouleau P,. [Simplified measurement of colonic transit time by one radiography of the abdomen and a single type of marker. Normal values in 82 volunteers related to the sexes]. Gastroenterol Clin Biol 1994; 18: 141-4.
16. Chan YK, Kwan AC, Yuen H, et al,. Normal colon transit time in healthy Chinese adults in Hong Kong. J Gastroenterol Hepatol 2004; 19: 1270-5.
17. Tougas G, Eaker EY, Abell TL, et al,. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol 2000; 95: 1456-62.
18. Hellmig S, Von Schoning F, Gadow C, et al,. Gastric emptying time of fluids and solids in healthy subjects determined by 13C breath tests: influence of age, sex and body mass index. J Gastroenterol Hepatol 2006; 21: 1832-8.
19. Miller MA, Parkman HP, Urbain JL, et al,. Comparison of scintigraphy and lactulose breath hydrogen test for assessment of orocecal transit: lactulose accelerates small bowel transit. Dig Dis Sci 1997; 42: 10-8.
20. Sadik R, Abrahamsson H, Stotzer PO,. Gender differences in gut transit shown with a newly developed radiological procedure. Scand J Gastroenterol 2003; 38: 36-42.
21. Medhus AW, Lofthus CM, Bredesen J, Husebye E,. Gastric emptying: the validity of the paracetamol absorption test adjusted for individual pharmacokinetics. Neurogastroenterol Motil 2001; 13: 179-85.
22. Szarka LA, Camilleri M, Vella A, et al,. A stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in research. Clin Gastroenterol Hepatol 2008; 6: 635-643 e1.
23. La Brooy SJ, Male PJ, Beavis AK, Misiewicz JJ,. Assessment of the reproducibility of the lactulose H2 breath test as a measure of mouth to caecum transit time. Gut 1983; 24: 893-6.
24. Darwiche G, Almer LO, Bjorgell O, Cederholm C, Nilsson P,. Measurement of gastric emptying by standardized real-time ultrasonography in healthy subjects and diabetic patients. J Ultrasound Med 1999; 18: 673-82.
25. Kuo B, McCallum RW, Koch KL, et al,. Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects. Aliment Pharmacol Ther 2008; 27: 186-96.
26. Rao SS, Kuo B, McCallum RW, et al,. Investigation of colonic and whole-gut transit with wireless motility capsule and radiopaque markers in constipation. Clin Gastroenterol Hepatol 2009; 7: 537-44.
27. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR,. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994; 69: 539-47.
28. Drossman DA, Dumitrascu DL,. Rome III: new standard for functional gastrointestinal disorders. J Gastrointestin Liver Dis 2006; 15: 237-41.
29. Svedlund J, Sjodin I, Dotevall G,. GSRS-a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988; 33: 129-34.
30. Cassilly D, Kantor S, Knight LC, et al,. Gastric emptying of a non-digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy. Neurogastroenterol Motil 2008; 20: 311-9.
31. Yen M, Lo LH,. Examining test-retest reliability: an intra-class correlation approach. Nurs Res 2002; 51: 59-62.
32. Maqbool S, Parkman HP, Friedenberg FK,. Wireless capsule motility: comparison of the SmartPill GI monitoring system with scintigraphy for measuring whole gut transit. Dig Dis Sci 2009; 54: 2167-74.
33. Camilleri M, Thorne NK, Ringel Y, et al,. Wireless pH-motility capsule for colonic transit: prospective comparison with radiopaque markers in chronic constipation. Neurogastroenterol Motil 2010; 22: 874-82, e233.
34. Minami H, McCallum RW,. The physiology and pathophysiology of gastric emptying in humans. Gastroenterology 1984; 86: 1592-610.
35. Metcalf AM, Phillips SF, Zinsmeister AR, MacCarty RL, Beart RW, Wolff BG,. Simplified assessment of segmental colonic transit. Gastroenterology 1987; 92: 40-7.
36. McLean RG, Smart RC, Lubowski DZ, King DW, Barbagallo S, Talley NA,. Oral colon transit scintigraphy using indium-111 DTPA: variability in healthy subjects. Int J Colorectal Dis 1992; 7: 173-6.
37. Bennink R, Peeters M, Van den Maegdenbergh V, et al,. Evaluation of small-bowel transit for solid and liquid test meal in healthy men and women. Eur J Nucl Med 1999; 26: 1560-6.
38. Malagelada JR, Robertson JS, Brown ML, et al,. Intestinal transit of solid and liquid components of a meal in health. Gastroenterology 1984; 87: 1255-63.
39. Wald A, Van Thiel DH, Hoechstetter L, et al,. Gastrointestinal transit: the effect of the menstrual cycle. Gastroenterology 1981; 80: 1497-500.
40. Kashyap PC, Marcobal A, Ursell LK, et al,. Complex interactions among diet, gastrointestinal transit, and gut microbiota in humanized mice. Gastroenterology 2013; 144: 967-77.
41. Halmos EP, Christophersen CT, Bird AR, Shepherd SJ, Gibson PR, Muir JG,. Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut 2015; 64: 93-100.
42. Reigstad CS, Salmonson CE, Rainey JF 3rd, et al,. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J 2015; 29: 1395-403.
43. Bampton PA, Dinning PG, Kennedy ML, Lubowski DZ, Cook IJ,. Prolonged multi-point recording of colonic manometry in the unprepared human colon: providing insight into potentially relevant pressure wave parameters. Am J Gastroenterol 2001; 96: 1838-48.
44. Abrahamsson H, Antov S, Bosaeus I,. Gastrointestinal and colonic segmental transit time evaluated by a single abdominal X-ray in healthy subjects and constipated patients. Scand J Gastroenterol Suppl 1988; 152: 72-80.
45. Bredenoord AJ, Fox M, Kahrilas PJ, et al,. Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil 2012; 24 (Suppl. 1): 57-65.
46. Stein E, Berger Z, Hutfless S, et al,. Wireless Motility Capsule Versus Other Diagnostic Technologies for Evaluating Gastroparesis and Constipation: A Comparative Effectiveness Review. Rockville, MD: AHRQ Comparative Effectiveness Reviews, 2013.
47. Watson BW, Meldrum SJ, Riddle HC, Brown RL, Sladen GE,. pH profile of gut as measured by radiotelemetry capsule. Br Med J 1972; 2: 104-6.
48. Evans DF, Pye G, Bramley R, Clark AG, Dyson TJ, Hardcastle JD,. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 1988; 29: 1035-41.
49. Bown RL, Gibson JA, Sladen GE, Hicks B, Dawson AM,. Effects of lactulose and other laxatives on ileal and colonic pH as measured by a radiotelemetry device. Gut 1974; 15: 999-1004.
50. Fallingborg J, Christensen LA, Ingeman-Nielsen M, Jacobsen BA, Abildgaard K, Rasmussen HH,. pH-profile and regional transit times of the normal gut measured by a radiotelemetry device. Aliment Pharmacol Ther 1989; 3: 605-13.
51. Zarate N, Mohammed SD, O'Shaughnessy E, et al,. Accurate localization of a fall in pH within the ileocecal region: validation using a dual-scintigraphic technique. Am J Physiol Gastrointest Liver Physiol 2010; 299: G1276-86.
52. Cummings JH, Macfarlane GT,. The control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol 1991; 70: 443-59.
53. Macfarlane GT, Gibson GR, Cummings JH,. Comparison of fermentation reactions in different regions of the human colon. J Appl Bacteriol 1992; 72: 57-64.
54. Farmer AD, Mohammed SD, Dukes GE, Scott SM, Hobson AR,. Caecal pH is a biomarker of excessive colonic fermentation. World J Gastroenterol 2014; 20: 5000-7.
55. Simren M, Barbara G, Flint HJ, et al,. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2013; 62: 159-76.
56. Ianiro G, Bibbò S, Gasbarrini A, Cammarota G,. Therapeutic modulation of gut microbiota: current clinical applications and future perspectives. Curr Drug Targets 2014; 15: 762-70.